4.3 Review

Food Additives, Gut Microbiota, and Irritable Bowel Syndrome: A Hidden Track

出版社

MDPI
DOI: 10.3390/ijerph17238816

关键词

food additives; IBS; microbiota; artificial sweeteners; polyols; emulsifiers; carboxymethylcellulose; polysorbate-80; titanium dioxide; food preservatives; personalized medicine

向作者/读者索取更多资源

The interactions between diet, gut microbiota, and irritable bowel syndrome (IBS) have many complex mechanisms that are not fully understood. Food additives are one component of the modern human diet that deserves attention from science and government policies. This review aims at identifying the current knowledge about the impact of food additives on gut microbiota and their potential role in the development of IBS. To date, few data on the effect of food additives on gut microbiota in IBS patients are available. However, exposure to food additives could induce the dysbiosis and dysregulation of gut homeostasis with an alteration of the gut barrier and activation of the immune response. These microbial changes could exacerbate the gut symptoms associated with IBS, such as visceral pain, low-grade inflammation, and changes in bowel habits. Some additives (polyols) are excluded in the low fermentable oligo-, di- and monosaccharide, and polyol (FODMAP), diets for IBS patients. Even if most studies have been performed in animals, and human studies are required, many artificial sweeteners, emulsifiers, and food colorants could represent a potential hidden driver of IBS, through gut microbiota alterations. Consequently, food additives should be preventively avoided in the diet as well as dietary supplements for patients with IBS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Effect of a Multistrain Probiotic on Leaky Gut in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study

Samira Ait Abdellah, Caroline Gal, Lucrezia Laterza, Venanzio Velenza, Carlo Romano Settanni, Marco Napoli, Elisa Schiavoni, Vincenzina Mora, Valentina Petito, Antonio Gasbarrini

Summary: This study suggests that a multistrain probiotic can reduce intestinal permeability in patients with IBS-D and confirmed leaky gut, leading to improvements in abdominal pain, stool consistency, and quality of life.

DIGESTIVE DISEASES (2023)

Article Medicine, General & Internal

The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma

Quirino Lai, Nicoletta De Matthaeis, Michele Finotti, Giovanni Galati, Giuseppe Marrone, Fabio Melandro, Filomena Morisco, Daniele Nicolini, Riccardo Pravisani, Edoardo G. Giannini

Summary: This study evaluates the impact of antiplatelet therapy on the incidence and mortality of hepatocellular carcinoma. The results suggest that antiplatelet therapy is associated with a reduced risk of HCC incidence and post-treatment mortality.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2023)

Review Biochemistry & Molecular Biology

The Gut-Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases

Natalia Di Tommaso, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani

Summary: The intestinal barrier is the first line of defense between the outside world and the intestine, and disruption can lead to increased intestinal permeability, causing intestinal and extra-intestinal diseases. The identification of a gut-vascular barrier has provided new evidence for the etiology and management of gut-liver axis and gut-brain axis diseases, with recent implications in oncology as well. The gut-brain axis is involved in neuroinflammatory processes, and the recent description of a choroid plexus vascular barrier regulating brain permeability under gut inflammation conditions identifies the endothelium as a key regulator in maintaining tissue homeostasis and health.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Nutrition & Dietetics

Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer

Ilaria Trestini, Alberto Caldart, Marco Cintoni, Isabella Sperduti, Alessandro Drudi, Gregorio Aluffi, Elena Fiorio, Veronica Parolin, Valentina Zambonin, Sara Zanelli, Daniela Tregnago, Alice Avancini, Sara Pilotto, Irene Aprili, Emanuela Zandona, Mirko D'Onofrio, Maria Cristina Mele, Antonio Gasbarrini, Giovanni Scambia, Giampaolo Tortora, Michele Milella, Emilio Bria, Luisa Carbognin

Summary: This study evaluated the changes in body composition during neoadjuvant chemotherapy and its association with pathologic complete response and survival outcome in patients treated for operable locally advanced breast cancer.

NUTRITION (2023)

Review Nutrition & Dietetics

Prevention and treatment of catheter-related venous thrombosis in long-term parenteral nutrition: A SINuC position statement

Vincenzo Zaccone, Luca Santoro, Emanuele Guerrieri, Ilaria Diblasi, Ilaria Roncarati, Giovanna Viticchi, Pietro Vecchiarelli, Angelo Santoliquido, Francesca Fiore, Alessio Molfino, Francesco Landi, Gianluca Moroncini, Antonio Gasbarrini, Maurizio Muscaritoli, Lorenzo Falsetti, SINuC

Summary: The implementation of long-term parenteral nutrition often requires central venous access, which carries a considerable risk of catheter-related venous thrombosis. The prevention and treatment of this condition in patients undergoing long-term parenteral nutrition is a gray area in the literature, with few randomized controlled clinical trials and a generally low level of evidence. The Italian Society of Clinical Nutrition and Metabolism conducted a narrative review and Delphi consensus to provide practical recommendations for the prevention, diagnosis, and treatment of catheter-related venous thrombosis in these patients.

FRONTIERS IN NUTRITION (2023)

Article Biochemistry & Molecular Biology

Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors

Maria Elena Ainora, Lucia Cerrito, Antonio Liguori, Irene Mignini, Angela De Luca, Linda Galasso, Matteo Garcovich, Laura Riccardi, Francesca Ponziani, Francesco Santopaolo, Maurizio Pompili, Antonio Gasbarrini, Maria Assunta Zocco

Summary: A correct differentiation between hepatocellular carcinoma (HCC) and intracellular cholangiocarcinoma (ICC) is essential but challenging. Dynamic contrast-enhanced ultrasound (D-CEUS) and shear wave elastography (SWE) can provide valuable information for accurate diagnosis. A multiparametric ultrasound (MP-US) score based on D-CEUS and SWE parameters showed high accuracy in distinguishing ICC from HCC, potentially reducing the need for liver biopsy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Gastroenterology & Hepatology

Update on the Role of Rifaximin in Digestive Diseases

Dan Dumitrascu, Igor Bakulin, Annalisa Berzigotti, Marilia Cravo, Laura Gombosova, Milan Lukas, Anna Pietrzak, Jose Maria Remes-Troche, Manuel Romero-Gomez, Mercedes Amieva Balmori, Tiago Curdia Goncalves, Lamine Hamzaoui, Radovan Juricek, Leticia Moreira, Katarzyna Neubauer, Teodora Surdea-Blaga, Igor N. Tikhonov, Jan Trna, Gianluca Ianiro, Francesca Romana Ponziani, Antonio Gasbarrini

Summary: Various environmental factors can lead to gut microbial imbalance and the development of diseases. Hepatic encephalopathy, irritable bowel syndrome, and diverticular disease are all related to dysfunction of the gut-liver-brain axis, but the pathophysiology differs for each condition.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2023)

Review Endocrinology & Metabolism

First-phase insulin secretion: can its evaluation direct therapeutic approaches?

Gianfranco Di Giuseppe, Gea Ciccarelli, Laura Soldovieri, Umberto Capece, Chiara M. A. Cefalo, Simona Moffa, Enrico C. Nista, Michela Brunetti, Francesca Cinti, Antonio Gasbarrini, Alfredo Pontecorvi, Andrea Giaccari, Teresa Mezza

Summary: Our work aims to investigate the role of the first-phase insulin secretion in the natural history of type 2 diabetes mellitus (T2DM) and its relationship with insulin resistance and beta cell function and mass. We explore the impact of impaired secretion on glucose homeostasis and emphasize the significance of postmeal hyperglycemia in disease management. Additionally, we review dietary and pharmacological approaches to improve early secretory defects and restore residual beta cell function, as well as discuss possible methods to detect early secretory defects in clinical practice.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2023)

Review Chemistry, Multidisciplinary

The Impact of Blenderized Tube Feeding on Gastrointestinal Symptoms, a Scoping Review

Elisabetta Sforza, Domenico Limongelli, Valentina Giorgio, Gaia Margiotta, Francesco Proli, Eliza Maria Kuczynska, Chiara Leoni, Donato Rigante, Ilaria Contaldo, Chiara Veredice, Emanuele Rinninella, Antonio Gasbarrini, Giuseppe Zampino, Roberta Onesimo

Summary: This study aimed to describe and quantify the impact of blenderized tube feeding (BTF) on gastrointestinal symptoms in children and adults. The results showed that gastrointestinal symptoms improved after consuming BTF, with a decrease of 30-50% in gagging and retching for children and similar improvement rates for constipation and diarrhea in most critically ill adults.

APPLIED SCIENCES-BASEL (2023)

Editorial Material Microbiology

Special Issue Gastrointestinal Microbiota and Gut Barrier Impact Human Health and Disease: Editorial

Pauline Raoul, Marco Cintoni, Emanuele Rinninella, Maria Cristina Mele

MICROORGANISMS (2023)

Review Biochemistry & Molecular Biology

Gut Microbiota, LADA, and Type 1 Diabetes Mellitus: An Evolving Relationship

Andrea Piccioni, Federico Rosa, Sergio Mannucci, Federica Manca, Giuseppe Merra, Sabrina Chiloiro, Marcello Candelli, Marcello Covino, Antonio Gasbarrini, Francesco Franceschi

Summary: This article focuses on the relationship between alterations in the gut microbiome and the onset of type 1 diabetes mellitus and LADA, based on the latest evidence. It discusses the crucial role of the gut microbiota in the pathogenesis of these disorders and explores how modulating the gut microbiota through probiotics, prebiotics, and fecal microbiota transplantation can lead to potential therapeutic strategies.

BIOMEDICINES (2023)

Review Cell Biology

Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies

Federica Di Vincenzo, Ylenia Yadid, Valentina Petito, Valeria Emoli, Letizia Masi, Daniela Gerovska, Marcos Jesus Arauzo-Bravo, Antonio Gasbarrini, Birgitte Regenberg, Franco Scaldaferri

Summary: Inflammatory bowel diseases (IBD), including Crohn's Disease (CD) and Ulcerative Colitis (UC), are chronic disorders affecting the gastrointestinal tract. The etiology and pathogenesis of IBD are still unknown, but recent studies suggest a potential role of cell-free DNAs (cfDNAs) and extrachromosomal circular DNA (eccDNA) in IBD. This review aims to collect and summarize available knowledge on cfDNAs, eccDNA, and their involvement in the pathogenesis of IBD. Potential molecular therapies and drug delivery systems for IBD treatment, such as nanoparticles, are also discussed.
Article Biochemistry & Molecular Biology

Impact of Immuno-Nutrition on the Nutritional Status, Inflammatory Response and Clinical Outcome of Clinic-Admitted Mild-Intensity-COVID-19 Patients: A Pilot, Perspective-Concluding Study

Martina Basilico, Marialaura Scarcella, Emanuele Rinninella, Nena Giostra, Stefano Marcelli, Carlo Rasetti, Jan Tack, Ludovico Abenavoli, Emidio Scarpellini

Summary: This study evaluated the impact of a standardized oral immuno-nutrition formula on COVID-19 patients. The findings showed that immuno-nutrition therapy can lower the levels of inflammatory markers, prevent the deterioration of BMI and phase angle, and prevent the development of malnutrition in overweight COVID-19 patients.

METABOLITES (2023)

Article Emergency Medicine

A new simple score to predict mortality of COVID-19 in the emergency department

Marcello Candelli, Giulia Pignataro, Marta Sacco Fernandez, Sara Cicchinelli, Antonio Gulli, Enrico Torelli, Maurizio Gabrielli, Andrea Piccioni, Marcello Covino, Veronica Ojetti, Massimo Antonelli, Antonio Gasbarrini, Francesco Franceschi

Summary: This study aims to evaluate clinical and laboratory indicators associated with mortality and determine a prognostic score based on these variables. A score called ANCOC (Age, blood urea Nitrogen, C-reactive protein, Oxygen saturation, Comorbidities) was created to predict the risk of death in COVID-19 patients. The ANCOC score showed high diagnostic accuracy in predicting mortality.

SIGNA VITAE (2023)

Review Medicine, Research & Experimental

Is there a role for microbiome-based approach in common variable immunodeficiency?

Remo Poto, Gianluca Laniro, Amato de Paulis, Giuseppe Spadaro, Gianni Marone, Antonio Gasbarrini, Gilda Varricchi

Summary: Common variable immunodeficiency (CVID) is a primary immunodeficiency characterized by low immunoglobulin levels and susceptibility to infections, autoimmune disorders, and cancer. The exact cause of CVID is unknown, but there is evidence supporting a link between the gut microbiome and CVID pathogenesis. This suggests that microbiome-based treatments, such as diet, prebiotics, probiotics, postbiotics, and fecal microbiota transplantation, could be potential therapeutic approaches for CVID.

CLINICAL AND EXPERIMENTAL MEDICINE (2023)

暂无数据